Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
The FDA will likely take Wegovy and Ozempic off the shortage list at some point
Our B12 Self-Injection Kits include detailed written instructions to demonstrate safe, intramuscular (IM) injection technique
Glutathione IVs generally combine glutathione with other vitamins and minerals to provide a super dose of antioxidants and rapidly aid cellular healing
Enzyme activity: NAD is used in processes such as metabolizing alcohol and converting lactate to pyruvate in the body
TRIUMPH-1 Phase 3 Trial Results Drawing attention to its efficiency, the TRIUMPH-1 Phase 3 trial showcased remarkable weight loss achievements